Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
about
Acute paranoid psychosis as sole clinical presentation of hepatic artery thrombosis after living donor liver transplantation.Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathySingle dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiencyCurrent concepts in the pathophysiology of hepatic encephalopathy.Endogenous benzodiazepine-like compounds and diazepam binding inhibitor in serum of patients with liver cirrhosis with and without overt encephalopathy.The delirium subtypes: a review of prevalence, phenomenology, pathophysiology, and treatment response.Neurochemistry of hepatic encephalopathyStrategies for hepatic support in acute liver failure: role of extracorporeal devices versus liver transplantation.Drugs and endogenous ligands compete for receptor occupancy.Purification and characterization of naturally occurring benzodiazepine receptor ligands in rat and human brain.Status epilepticus after ligation of portosystemic shunts.Practical Issues in the Management of Overt Hepatic Encephalopathy.Endogenous benzodiazepine activity in the peripheral and portal blood of dogs with congenital portosystemic shunts.Brain uptake of iomazenil in cirrhotic patients: a single photon emission tomography study.Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy.Reversal of prolonged sedation using flumazenil in critically ill patients.
P2860
Q33533483-BB8AA5C1-8DA1-4429-A871-75F7F72287D1Q33680275-207F3081-89C3-4100-845A-212F221ED745Q34358359-AF19403B-9EAF-4B62-9FAC-F09B055EEDEBQ35273120-346F6EE7-6F11-4443-852D-D259850F2E52Q35351209-027653EF-870D-4B96-9E0B-CB77296EDF77Q36440129-12AC6AC0-6064-48E7-AAAA-25C9C95008E5Q36831314-124853A7-5C66-4C1B-B87B-B3AD49C9F36DQ38218754-4C893EEE-DFD5-47AA-AF7E-8185D6DCACCCQ40518019-E0D195C1-269E-4425-88F6-4F3C8F0185BAQ43762675-25437C95-E64D-4712-B17A-677B9E0BADF8Q44582431-61360766-74DE-4B1E-B6E9-087C025C1833Q46109624-117F701E-2998-42C9-80AD-237F7B142943Q46559033-65DB0C4A-5A23-40B3-83D6-D518BB914DBDQ48097527-D40052AF-248E-447B-8A26-6362097FBB2EQ48847887-D562011F-446A-415E-A7FB-C212576124B6Q51752091-77FB3CD6-197C-45AF-9464-9D07A97C21FC
P2860
Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
@en
Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
@nl
type
label
Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
@en
Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
@nl
prefLabel
Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
@en
Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
@nl
P2093
P1433
P1476
Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
@en
P2093
J V Martin
K D Mullen
M L Bassett
W B Mendelson
P304
P356
10.1016/S0140-6736(88)91245-7
P407
P577
1988-02-01T00:00:00Z